Differential Involvement of P-Glycoprotein (ABCB1) in Permeability, Tissue Distribution, and Antinociceptive Activity of Methadone, Buprenorphine, and Diprenorphine: In Vitro and In Vivo Evaluation-Reference-Cited by-同舟云学术

Differential Involvement of P-Glycoprotein (ABCB1) in Permeability, Tissue Distribution, and Antinociceptive Activity of Methadone, Buprenorphine, and Diprenorphine: In Vitro and In Vivo Evaluation

Published:2009-12 Issue:12 Volume:98 Page:4928-4940
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Hassan Hazem E.,Myers Alan L.,Coop Andrew,Eddington Natalie D.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs;Mahar Doan;J Pharmacol Exp Ther,2002

2. Transporter-mediated permeation of drugs across the blood-brain barrier;Tamai;J Pharm Sci,2000

3. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins;Schinkel;Proc Natl Acad Sci USA,1997

4. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A;Schinkel;J Clin Invest,1995

5. The functional role of P-glycoprotein in the blood-brain barrier;van Asperen;J Pharm Sci,1997

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania;British Journal of Clinical Pharmacology;2024-07-11

2. Comparative Anesthesia and Analgesia – Dogs and Cats;Veterinary Anesthesia and Analgesia;2024-06-21

3. Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability;Drug Metabolism and Disposition;2024-05-20

4. Forecasting Fetal Buprenorphine Exposure through Maternal–Fetal Physiologically Based Pharmacokinetic Modeling;Pharmaceutics;2024-03-08

5. Evaluating the Pharmacokinetics of Fentanyl in the Brain Extracellular Fluid, Saliva, Urine, and Plasma of Newborns from Transplacental Exposure from Parturient Mothers Dosed with Epidural Fentanyl Utilizing PBPK Modeling;European Journal of Drug Metabolism and Pharmacokinetics;2023-08-10